DRLDS Pep-LNP

Name: DRLDS Pep-LNP
SKU: TDLD-0126-LD82
Rating: 5 (1 reviews)

Cat. No.: TDLD-0126-LD82

DRLDS Pep-LNP

DRLDS Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) engineered with the DRLDS peptide, designed for targeted delivery of therapeutic cargoes. It offers enhanced stability, prolonged circulation, and specific tissue accumulation, suitable for developing targeted therapeutics and studying peptide-mediated delivery mechanisms. Please note that this product is intended for research purposes only.

Inquiry

SPECIFIC INQUIRY

Payload:

Modification:

Lipid Formulation:

Dye:

Concentration:

Quantity:

Clear All Inquiry

For Research Use Only. Not for Diagnostic or Treatment Applications.

Payload Type	mRNA
Payload	Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others
Capping	Cap 1
Modification	Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other

Module Type	Peptide
Targeting Module	DRLDS Peptide

Target	Tumor
Lipid Formulation	DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other
Dye	Unlabeled; DiR; DiD; DiO; DiI; Other
Application	Control; Targeted Delivery; Gene Therapy
Format	Liquid
Concentration	0.1 mg/mL; 0.2 mg/mL; Other (Please Specify)

Size	65-120 nm
PDI	< 0.2
Zeta	± 20.0 mV
Encapsulate Efficiency	>90%

Shipping	Dry Ice
Storage	Store at -80°C